Current status and progress of the treatment of acute promyelocytic leukemia / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
; (12): 546-549, 2019.
Article
en Zh
| WPRIM
| ID: wpr-798247
Biblioteca responsable:
WPRO
ABSTRACT
Acute promyelocytic leukemia (APL) is a special type of acute leukemia. The cure rate of APL has been significantly improved in the past decades due to the use of anthracyclines, all-trans retinoic acid and arsenic. Modern stratified treatment of APL further enhances the therapeutic efficacy and reduces the treatment-related toxicity. This article reviews the history of all-trans retinoic acid and arsenic into clinical application, and the characteristics of disease, treatment status of all-trans retinoic acid and arsenic, treatment mechanism and drug resistance mechanism in APL are introduced.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Journal of Leukemia & Lymphoma
Año:
2019
Tipo del documento:
Article